Guidelines for prescribing azathioprine in dermatology

No abstract is available for this paper.

• Publication year

  2004

• Venue

  British Journal of Dermatology

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2133.2004.06323.xPMID 15606506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is immunosuppression therapy in renal allograft recipients teratogenic? A single‐center experience

  2003cited by this paper
• Guidelines for the management of pemphigus vulgaris

  2003cited by this paper
• The British Association of Dermatologists therapeutic guidelines: can we AGREE?

  2003cited by this paper
• Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK.

  2002cited by this paper
• A systematic review of treatments for bullous pemphigoid.

  2002cited by this paper
• Guidelines for the management of bullous pemphigoid

  2002cited by this paper
• 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

  2002cited by this paper
• Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease

  2002cited by this paper
• TPMT in the treatment of Crohn's disease with azathioprine

  2002cited by this paper
• Pharmacogenetics in clinical dermatology

  2002cited by this paper
• Azathioprine in severe adult atopic dermatitis: a double‐blind, placebo‐controlled, crossover trial

  2002cited by this paper
• A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression

  2002cited by this paper
• The treatment of inflammatory bowel disease with 6‐mercaptopurine or azathioprine

  2001cited by this paper
• Azathioprine for atopic dermatitis

  2001cited by this paper
• Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

  2000cited by this paper
• A comparison of molecular and enzyme‐based assays for the detection of thiopurine methyltransferase mutations

  2000cited by this paper
• Azathioprine for rheumatoid arthritis.

  2000cited by this paper
• Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia

  2000cited by this paper
• Pharmacogenetics as a Molecular Basis for Individualized Drug Therapy: The Thiopurine S-methyltransferase Paradigm

  1999cited by this paper
• The British Association of Dermatologists guidelines for the management of skin disease

  1999cited by this paper
• Principles of epidemiological research on adverse and beneficial drug effects.

  1998cited by this paper
• Retrospective review of the use of azathioprine in severe atopic dermatitis.

  1996cited by this paper
• Treatment of pyoderma gangrenosum.

  1996cited by this paper
• Erosive and generalized lichen planus responsive to azathioprine

  1996cited by this paper
• Azathioprine in dermatology: a review in the light of advances in understanding methylation pharmacogenetics.

  1995cited by this paper
• The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.

  1995cited by this paper
• Azathioprine hypersensitivity‐like reations–a case report and a review of the literature

  1995cited by this paper
• Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.

  1994cited by this paper
• Azathioprine-induced shock in dermatology patients.

  1993cited by this paper
• Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.

  1993cited by this paper
• Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid.

  1993cited by this paper
• Lack of predictive factors for the clinical course of bullous pemphigoid.

  1992cited by this paper
• Pancytopenia Related to Azathioprine — An Enzyme Deficiency Caused by a Common Genetic Polymorphism: A Review

  1992cited by this paper
• Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis.

  1991cited by this paper
• A controlled trial of azathioprine in Behçet's syndrome.

  1990cited by this paper
• Azathioprine treatment in chronic actinic dermatitis: a double‐blind controlled trial with monitoring of exposure to ultraviolet radiation

  1989cited by this paper
• Pancytopenia related to azathioprine in rheumatoid arthritis.

  1988cited by this paper
• Azathioprine hypersensitivity: Case report and review of the literature

  1988cited by this paper
• Azathioprine lymphocytotoxicity. Potentially lethal damage by its imidazole derivatives.

  1988cited by this paper
• Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study.

  1988cited by this paper
• Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up.

  1987cited by this paper
• Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients

  1985cited by this paper
• Azathioprine-induced pancytopenia. Occurrence in two patients with connective-tissue diseases.

  1981cited by this paper
• Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

  1980cited by this paper
• SUCCESSFUL PREGNANCIES IN WOMEN TREATED BY DIALYSIS AND KIDNEY TRANSPLANTATION

  1980cited by this paper
• Viral infections in renal allograft recipients treated with long-term immunosuppression.

  1979cited by this paper
• Azathioprine-related pancreatitis in patients with Crohn's disease.

  1979cited by this paper
• A controlled trial of azathioprine in the treatment of pemphigoid

  1978cited by this paper
• Wegener's granulomatosis—controlled by azathioprine and corticosteroids

  1975cited by this paper
• Treatment of Psoriasis with Azathioprine

  1974cited by this paper
• Immunosuppression and Neoplasia

  1973cited by this paper
• Immunosuppression and neoplasia

  1973cited by this paper
• Risk of cancer in renal-transplant recipients.

  1973cited by this paper
• Oncogenicity of immunosuppressive drugs.

  1972cited by this paper
• TREATMENT OF PITYRIASIS RUBRA PILARIS WITH AZATHIOPRINE

  1972cited by this paper

• Azathioprine for remission maintenance in anti-interferon-γ autoantibody-associated immunodeficiency syndrome- a retrospective single-center cohort study

  2026cites this paper
• Efficacy and Safety of Baricitinib Versus Azathioprine Combined with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis: A Single-Center, Randomized, Open-Label Trial.

  2025cites this paper
• Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and Long COVID: current state and future direction

  2025influential citation
• Concomitant Alopecia Areata and Profound Bone Marrow Suppression: An Unusual Manifestation of Azathioprine Toxicity

  2025cites this paper
• Trends in Precision Medicine and Pharmacogenetics as an Adjuvant in Establishing a Correct Immunosuppressive Therapy for Kidney Transplant: An Up-to-Date Historical Overview

  2025influential citation
• Value of Azathioprine in Controlling Vitiligo Activity

  2025cites this paper
• Azathioprine Hypersensitivity Syndrome Mimicking an Infection in a Systemic Lupus Erythematosus Patient: A Case Report

  2025cites this paper
• Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial

  2024cites this paper
• Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease

  2023cites this paper
• Lichen planus – A refractory autoimmune disorder

  2023cites this paper
• Azathioprine-Induced Marrow Suppression in Dermatology Patients - Analysis of 18 Patients

  2022cites this paper
• Azathioprine

  2022cites this paper
• Malignancy risk of non‐biologic immunosuppressive therapies: A review of the literature with evidence‐based treatment recommendations

  2022cites this paper
• A comprehensive review of immunosuppressive drugs in pediatric dermatoses: Part I - Corticosteroids, azathioprine, and cyclosporine-A

  2022cites this paper
• PGPM_A_285033 179..187

  2021cites this paper
• The Association Between Azathioprine Genetic Polymorphisms, Clinical Efficacy and Adverse Drug Reactions Among Egyptian Patients with Autoimmune Diseases

  2021cites this paper
• Hematologic Toxicity of Drug Therapy

  2021cites this paper
• Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis

  2020cites this paper
• Azatioprina: usos em dermatologia

  2020cites this paper
• Therapy of Allergic and Irritant Contact Dermatitis

  2020cites this paper
• Azathioprine: its uses in dermatology⋆⋆⋆

  2020influential citation
• Tacrolimus for Treating Orbital and Cranial Form of Idiopathic Inflammatory Pseudotumors

  2020cites this paper
• TCRM_A_257714 651..662

  2020cites this paper
• Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

  2020cites this paper
• Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days

  2020cites this paper
• COVID‐19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement

  2020cites this paper
• Chapter 18: Oncology: Mercaptopurine/TPMT Case

  2020cites this paper
• Chapter 25: Rheumatology/Musculoskeletal Pain: Azathioprine/TPMT, Celecoxib/CYP2C9 Case

  2020cites this paper
• Sulfasalazine in dermatology: A lesser explored drug with broad therapeutic potential

  2020cites this paper
• Update of Treatment Options in Atopic Dermatitis: A Narrative Review

  2019cites this paper
• Treatment of Chronic Hand Eczema: Other Immunomodulating Therapies

  2019cites this paper
• Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

  2019cites this paper
• Efficacy and safety of azathioprine in alopecia areata

  2019influential citation
• Pharmacotherapeutic Approaches in Oral Medicine

  2019cites this paper
• Annular Erythema Proved to Be an Unusual Disorder

  2019cites this paper
• Emerging treatment options for the management of pemphigus vulgaris

  2018cites this paper
• UV-Visible Spectrophotometric Determination of Azathioprine in Pharmaceutical Formulations Based on Oxidative coupling reaction with MBTH

  2018cites this paper
• Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update

  2018cites this paper
• Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients.

  2017cites this paper
• A Case Report of Azathioprine and Phenytoin Induced Hepatitis

  2017cites this paper
• Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease

  2016cites this paper
• Hypersensitivity pneumonitis associated with azathioprine therapy in a patient with granulomatosis with polyangiitis

  2016cites this paper
• STEČENE BULOZNE DERMATOZE

  2015cites this paper
• Hand Dermatitis: A Review of Clinical Features, Prevention and Treatment

  2015influential citation
• Indian Society of Gastroenterology consensus statements on Crohn’s disease in India

  2015cites this paper
• Association between Thiopurine S-methyltransferase Polymorphisms and Thiopurine-Induced Adverse Drug Reactions in Patients with Inflammatory Bowel Disease: A Meta-Analysis

  2015cites this paper
• Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis

  2015cites this paper
• Management of pemphigus vulgaris: challenges and solutions

  2015cites this paper
• The Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus

  2015cites this paper
• Royal jelly attenuates azathioprine induced toxicity in rats.

  2014cites this paper
• Cost-effectiveness of alitretinoin (Toctino) for severe chronic hand eczema in adults

  2014cites this paper
• Diagnostic approach in patients with suspected vasculitis.

  2014cites this paper
• Azathioprine-related Myelosuppression in a Patient Homozygous for TPMT*3C

  2014cites this paper
• Using systems approaches to address challenges for clinical implementation of pharmacogenomics

  2014cites this paper
• Implementation of TPMT testing.

  2014cites this paper
• VALIDATED STABILITY-INDICATING RP-HPLC ASSAY METHOD FOR AZATHIOPRINE IN PHARMACEUTICAL DOSAGE FORM ACCORDING TO ICH GUIDELINES

  2014cites this paper
• Testing for thiopurine methyltransferase status for safe and effective thiopurine administration: a systematic review of clinical guidance documents

  2014cites this paper
• Using systems approaches to address challenges for clinical implementation of

  2014cites this paper
• Correlation of thiopurine methyltransferase and inosine triphosphate pyrophosphatase polymorphisms and adverse effects induced by azathioprine treatment in Taiwanese dermatology patients

  2014cites this paper
• Pharmacogenetics in dermatology: a patient‐centered update

  2013cites this paper
• Neutrophilic dermatosis after azathioprine exposure.

  2013cites this paper
• Systemic use of non-biologics in orofacial diseases: 2. Purine synthesis inhibitors.

  2013cites this paper
• 22 – Comment gérer un traitement immunosuppresseur ?

  2013cites this paper
• Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris.

  2013cites this paper
• Thiopurine Dosing using Thiopurine Methyltransferase Status: A Systematic Review of Clinical Guidance

  2013cites this paper
• Thiopurine methyltransferase screening before azathioprine prescription: a physician survey.

  2013cites this paper
• Pemfigusun Güncel Tedavisi ve Yönetimi

  2012cites this paper
• Immunosuppressive therapy for autoimmune bullous diseases.

  2012cites this paper
• Current therapy of the pemphigus group.

  2012cites this paper
• Hand eczema: an update.

  2012cites this paper
• Diagnosis and treatment of pemphigus.

  2012cites this paper
• PEMPHIGUS CHRONICUS VULGARIS - PRIKAZ BOLESNIKA

  2012cites this paper
• Pharmacogenetics and Its Applications in Rheumatology

  2012cites this paper
• Current Management of Pemphigus

  2012cites this paper
• Azathioprine induced cholestatic hepatitis

  2011cites this paper
• A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.

  2011cites this paper
• Pharmacogenetics: Mismatches between policy and practice

  2011cites this paper
• Características epidemiológicas, clínicas y supervivencia de pacientes con diagnóstico de pénfigo atendidos en el Hospital Regional Docente de trujillo. Período 1994-2006

  2011cites this paper
• Pharmacogenetic Testing: Time for Clinical Practice Guidelines

  2011cites this paper
• Systemic drugs in patients with skin diseases.

  2011cites this paper
• Systemic treatment for alopecia areata

  2011cites this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

  2011cites this paper
• Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity

  2011cites this paper
• Biologic Agents in Psoriasis: British Association of Dermatologists' Guidelines for Biologic Intervention for Psoriasis 2009

  2011cites this paper
• Psoriasis: conceptos actuales en el tratamiento sistémico. Parte 2. Medicamentos biológicos y no tradicionales

  2011cites this paper
• Valuing pharmacogenetic testing services: a comparison of patients' and health care professionals' preferences.

  2011cites this paper
• Therapy and Rehabilitation of Allergic and Irritant Contact Dermatitis

  2011cites this paper
• Assessment of Thiopurine S-Methyltransferase Activity in Patients Prescribed Thiopurines: A Systematic Review

  2011cites this paper
• Pharmacogenetics and Pharmacogenomics II: Genetic Determinants of Drug Responses and Adverse Drug Reactions

  2011cites this paper
• Nonclinical influences, beyond diagnosis and severity, on clinical decision making in dermatology: understanding the gap between guidelines and practice

  2010cites this paper
• Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study

  2010cites this paper
• An audit of thiopurine methyltransferase genotyping and phenotyping before intended azathioprine treatment for dermatological conditions

  2010cites this paper
• Metabolic and genetic aspects of thiopurine metabolism

  2010cites this paper
• The actual management of pemphigus.

  2010cites this paper
• Outcome of patients on azathioprine: a need for a better pre-treatment assessment and dosing guideline.

  2010cites this paper
• Azathioprine-induced carcinogenesis in mice according to Msh2 genotype.

  2010cites this paper
• How genetic variation affects patient response and outcome to therapy for psoriasis

  2010cites this paper
• Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come

  2010influential citation
• Chapitre 56 – Immunosuppresseurs et immunomodulateurs

  2010cites this paper
• Expressing thiopurine S-methyltransferase activity as units per litre of whole-blood overcomes misleading high results in patients with anaemia

  2010cites this paper